Sociedad Americana de Hirudoterapia

Flap Venous Congestion and Salvage Techniques: A Systematic Literature Review

Research article published in Plastic and reconstructive surgery. Global open (2021)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de evidenciaReferencia del artículo
Evidence: Research reportEnsayos clínicosBoissiere F et al. · Plastic and reconstructive surgery. Global open, 2021

Abstract

UNLABELLED: Venous congestion is a frequent problem in flap surgery. Other than surgical revision, there are a multitude of procedures in the literature to tackle this problem, but their effectiveness is not clear. Through a systematic review, we aimed to identify and evaluate the different interventions available for managing flap venous congestion. METHODS: The MEDLINE, PubMed central, Embase, and Cochrane databases were searched. The study selection process was adapted from the PRISMA statement. All English and French original articles describing or comparing a method for managing flap venous congestion were included. For each article, a level of evidence was assigned, as defined by the Oxford Centre for Evidence-based Medicine. Lastly, we specifically analyzed the effectiveness of postoperative non-surgical methods. No formal analysis was performed. RESULTS: Through literature searches carried out in various databases, we identified 224 articles. Finally, 72 articles were included. The majority of these studies had a low-level evidence. A total of 17 different methods (7 pre- and intraoperative, and 10 postoperative) were found. Concerning non-surgical methods, the most represented were leeches, local subcutaneous injection of heparin with scarification, venocutaneous catheterization, negative pressure therapy, and hyperbaric oxygen therapy. CONCLUSIONS: Risks of venous congestion of flaps must always be present in a surgeon's mind, at every stage of flap surgery. Apart from studies on the use of leeches, which have a significant follow-up and large enough patient numbers to support their efficacy, the low-level evidence associated with studies of other methods of venous congestion management does not allow us to draw a scientifically valid conclusion about their effectiveness.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Resumen

Venous congestion is a frequent problem in flap surgery.

Por qué esto importa para la hirudoterapia

Esta revisión sistemática de la literatura identificó y evaluó 72 artículos que describían intervenciones para el manejo de la congestión venosa en cirugía de colgajos, encontrando 17 técnicas diferentes (7 pre/intraoperatorias y 10 postoperatorias) con evidencia generalmente de bajo nivel. Notablemente, la terapia con sanguijuelas fue identificada como el método no quirúrgico más representado y la única intervención con estudios de duración de seguimiento y número de pacientes suficientes para respaldar su eficacia. Esto es directamente relevante para el ámbito de ASH, ya que afirma la terapia con sanguijuelas medicinales como el tratamiento conservador con mejor evidencia para la congestión venosa de los colgajos en cirugía reconstructiva, una aplicación moderna fundamental de la hirudoterapia. La revisión es descriptiva, sin metanálisis formal, y la base de evidencia general para la mayoría de los métodos alternativos sigue siendo débil.

Citación

Flap Venous Congestion and Salvage Techniques: A Systematic Literature Review

Boissiere F et al. · Plastic and reconstructive surgery. Global open, 2021

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.